StackTerminal.Health

BETA

Vitamin K2 (MK-7)

Menaquinone-7 (MK-7) is the long-chain form of vitamin K2 that activates matrix Gla-protein & osteocalcin, directing calcium to bone rather than arterial walls; evidence from RCTs demonstrates preservation of bone mineral density & reduction of vertebral height loss in postmenopausal women.

bonecardiovascularlongevitycalcium-metabolismhormonal
Evidence last reviewed: 04 Apr 2026
Supplement note
Private note on this supplement

Save how you reacted, what dose worked, what to watch for, or anything you want to remember later in your Notes tab.

Sign in to keep a private note on Vitamin K2 (MK-7).
Evidence
2 records
Bone mineral density & vertebral fracture prevention
Healthy postmenopausal womenRCT
PUBMEDModerate

A 3-year double-blind RCT (n=244) of MK-7 180 mcg/day found significantly attenuated age-related decline in bone mineral content & BMD at lumbar spine & femoral neck versus placebo, plus reduced vertebral height loss in the lower thoracic region; bone strength indices were also favorably affected.

Dose: 0 mgDuration: 3 years
Dose expressed in mg (180 mcg = 0.18 mg). MK-7 has a ~72-hour half-life enabling once-daily dosing.
Fracture incidence & bone density in postmenopausal osteoporosis
Postmenopausal women with or at risk for osteoporosissystematic review and meta-analysis of RCTs
PUBMEDModerate

Meta-analysis of 16 RCTs (n=6,425) found vitamin K2 supplementation significantly improved lumbar spine BMD & reduced fracture incidence after exclusion of one outlier study; undercarboxylated osteocalcin was consistently reduced, indicating enhanced bone mineralization.

Dose: 0 mgDuration: 6 months – 3 years
Forms

Stacks containing Vitamin K2 (MK-7)

Public community stacks that include this ingredient.

Explore all stacks →
No public stacks include this ingredient yet.